我要投票 腾药Tengyao在乌鸡白凤丸行业中的票数:368
· 外 推 电 报 ·
2025-05-04 11:43:09 星期日

【腾药Tengyao是哪个国家的品牌?】

腾药Tengyao是什么牌子?「腾药Tengyao」是 云南腾药制药股份有限公司 旗下著名品牌。该品牌发源于云南省保山市,由创始人赵丙贤在1990-06-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力腾药Tengyao品牌出海!将品牌入驻外推网,定制腾药Tengyao品牌推广信息,可以显著提高腾药Tengyao产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

云南腾药制药股份有限公司(以下简称“腾药”)成立于1956年,1997年改为股份合作制企业,2011年9月在县委政府的关心支持下完成股份制改造,同年11月与北京中证万融医药投资集团实现战略合作。

历经五十多年历史积淀的腾药,目前在编在岗员工600余人(含销售人员),具备了雄厚的制药技术基础,公司在不断汲取现代科学技术的基础上具备了专业的检测手段。两者的有机结合,使“腾药”产品有了过硬的质量,造就的品种有心脉隆注射液、安宫牛黄丸、人参再造丸、六味地黄丸、六灵丸、藿香正气水、感冒疏风片、清肺抑火片等。年生产规模为2000多吨,主要剂型有注射剂、丸剂(大蜜丸、小蜜丸、水丸、水蜜丸)、片剂、颗粒剂、散剂、酒剂、酊剂、糖浆剂,国药准字批文 130个,87个品种,137个品规,均是中药、天然药物。其中,国家二类新药“心脉隆注射液”由企业与大理学院联合研制,于2007年获准生产上市,为腾药的发展注入了新的活力。

规划:发展为以心脉隆注射液为主,传统普药为辅,日化保健品为补的上市企业。

党建:公司党总支下设5个党支部,共有党员62名(其中女党员37名)。

文化:公司起源于药王宫(建于明代天启六年)——全国中医药文化宣传教育基地,整个以求健康、传健康、学健康、食健康为主。公司秉承诚信制药,争做百年腾药。公司核心使命:“为人类健康创造卓越价值”,核心价值:“顾客第一服务他人 诚信 创新”。

诚信:公司一直秉承诚信制药的优良传承,用“宁为上药三分利,莫负良医九折肱”的对联警醒着一代又一代制药人。

创新:以心脉隆注射液为主的科研课题研究、美蠊系列日化保健品开发。


英文翻译:Yunnan tengyao Pharmaceutical Co., Ltd. (hereinafter referred to as "tengyao") was founded in 1956, changed into a joint-stock cooperative enterprise in 1997, completed the joint-stock transformation in September 2011 with the care and support of the county Party committee and government, and achieved strategic cooperation with Beijing Zhongzheng Wanrong pharmaceutical investment group in November of the same year. After more than 50 years of historical accumulation, tengyao has more than 600 employees (including sales staff) on the job at present, with a strong pharmaceutical technology foundation, and the company has a professional testing method based on continuous learning of modern science and technology. The organic combination of the two makes the "tengyao" products have excellent quality. The varieties created are Xinmailong injection, Angongniuhuang pill, Renshen Zaizai pill, Liuwei Dihuang pill, Liuling pill, Huoxiang Zhengqi water, Ganmao Shufeng tablet, Qingfei Yihuo tablet, etc. The annual production scale is more than 2000 tons, and the main dosage forms are injection, pill (big honey pill, small honey pill, water pill, water honey pill), tablet, granule, powder, liquor, tincture, syrup. There are 130 national drug approval documents, 87 varieties, 137 product specifications, all of which are traditional Chinese medicine and natural medicine. Among them, Xinmailong injection, a national second-class new drug, was jointly developed by the enterprise and Dali University, and was approved for production and listing in 2007, which injected new vitality into the development of tengyao. Planning: to develop into a listed enterprise mainly with Xinmailong injection, supplemented by traditional general medicine and supplemented by daily chemical health products. Party Construction: the company has 5 party branches under the general Party branch, with 62 party members (including 37 female party members). Culture: the company originated in the palace of Medicine (built in the sixth year of Tianqi in Ming Dynasty) - the national base of traditional Chinese medicine culture publicity and education, focusing on health, transmission, learning and eating. The company adheres to the integrity of pharmaceutical, striving to be a century drug. The company's core mission: "to create outstanding value for human health", and its core value: "customer first, serve others and innovate with integrity". Integrity: the company has always been adhering to the good heritage of integrity pharmaceutical, with the couplet of "better for the third profit of the drug, better for the nine fold arm" to alert generations of pharmaceutical people. Innovation: Research on Xinmailong injection as the main scientific research topic, and development of Periplaneta americana series of daily chemical health products.

本文链接: https://www.waitui.com/brand/19813d252.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美国4月关税收入超170亿美元

当地时间5月3日,据雅虎财经报道,美国特朗普政府在4月份征收了超过174亿美元的“关税和某些消费税”。报道称,这几乎是3月份96亿美元收入的两倍,也远超特朗普第一任期内的任何收入。自1月1日以来,这些关税已累计为政府注入了超过700亿美元的收入。特朗普此前在节目中表示,随着数十亿美元的关税收入涌入,美国“才刚刚开始”。

2小时前

伯克希尔哈撒韦Q1净利润降至46亿美元,同比减少64%

伯克希尔哈撒韦第一季度净利润46.03亿美元,同比减少64%,上年同期盈利127.02亿美元;第一季度营收897.25亿美元,上年同期898.69亿美元;第一季度投资净亏损50.38亿美元,上年同期盈利14.8亿美元。

2小时前

巴菲特谈巨额现金储备

巴菲特在伯克希尔・哈撒韦股东大会上表示,伯克希尔现金数量确实是相当高,但好的机会不会每一天都出现。不正确或不正当的投资,反而会损害投资人的利益。巴菲特表示,他一直在寻找投资机会,并希望减少手头现金——可能降至500亿美元。事情偶尔会变得极具吸引力。重大交易“极不可能”明天就发生,但在五年内则并非如此。之所以赚了很多钱,是因为从未全仓投资。

2小时前

巴菲特评价苹果CEO:“库克为伯克希尔赚的钱,比我为伯克希尔哈撒韦赚的还多。”

巴菲特在伯克希尔・哈撒韦股东大会上提到库克称,很高兴苹果CEO库克先生也到场了,在乔布斯逝世之后,库克接手苹果同样做得非常出色,没有人能像乔布斯一样,但库克对苹果也有很大建树。巴菲特打趣道,“说来有点难为情,库克为伯克希尔赚的钱,比我为伯克希尔哈撒韦赚的还多。”

2小时前

年轻投资者如何塑造投资理念?巴菲特:与更优秀的人为伍

谈及年轻投资者应该如何塑造他们的投资理念时,巴菲特表示,你交往的人非常重要。“你应该和比你优秀的人在一起,”他说。“你会朝着你所交往的人的方向前进。”

2小时前

本页详细列出关于腾药Tengyao的品牌信息,含品牌所属公司介绍,腾药Tengyao所处行业的品牌地位及优势。
咨询